Literature DB >> 23795754

Real-time PCR-assay in the delivery suite for determination of group B streptococcal colonization in a setting with risk-based antibiotic prophylaxis.

Stellan Håkansson1, Karin Källén, Maria Bullarbo, Per-Åke Holmgren, Katarina Bremme, Asa Larsson, Margareta Norman, Håkan Norén, Catharina Ortmark-Wrede, Karin Pettersson, Sissel Saltvedt, Birgitta Sondell, Magdalena Tokarska, Anna von Vultee, Bo Jacobsson.   

Abstract

OBJECTIVE: Intrapartum antibiotic prophylaxis (IAP) reduces the incidence of neonatal early onset group B streptococcal infections. The present study investigated if an automated PCR-assay, used bedside by the labor ward personnel was manageable and could decrease the use of IAP in a setting with a risk-based IAP strategy.
METHODS: The study comprises two phases. Phase 1 was a multicenter, randomized, controlled trial. Women with selected risk-factors were allocated either to PCR-IAP (prophylaxis given if positive or indeterminate) or IAP. A vaginal/rectal swab and superficial swabs from the neonate for conventional culture were also obtained. Phase 2 was non-randomized, assessing an improved version of the assay.
RESULTS: Phase 1 included 112 women in the PCR-IAP group and 117 in the IAP group. Excluding indeterminate results, the assay showed a sensitivity of 89% and a specificity of 90%. In 44 % of the PCR assays the result was indeterminate. The use of IAP was lower in the PCR group (53 versus 92%). Phase 2 included 94 women. The proportion of indeterminate results was reduced (15%). The GBS colonization rate was 31%.
CONCLUSION: The PCR assay, in the hands of labor ward personnel, can be useful for selection of women to which IAP should be offered.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23795754     DOI: 10.3109/14767058.2013.818128

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  3 in total

1.  Multicenter clinical evaluation of the Xpert GBS LB assay for detection of group B Streptococcus in prenatal screening specimens.

Authors:  Blake W Buchan; Matthew L Faron; DeAnna Fuller; Thomas E Davis; Donna Mayne; Nathan A Ledeboer
Journal:  J Clin Microbiol       Date:  2014-11-19       Impact factor: 5.948

2.  Intrapartum PCR-assay for detection of Group B Streptococci (GBS).

Authors:  Rikke B Helmig; Jan B Gertsen
Journal:  Eur J Obstet Gynecol Reprod Biol X       Date:  2019-06-27

3.  A comparison of GenomEra® GBS PCR and GeneXpert ® GBS PCR assays with culture of GBS performed with and without broth pre-enrichment.

Authors:  S Y Nielsen; J K Møller; M R Khalil
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-06-13       Impact factor: 3.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.